WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Buy
Wall Street Data Solutions Rating
Neutral
B
ALX Oncology Holdings Inc. Common Stock (ALXO)
Pharmaceutical Preparations
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/17/2020
Market Cap
136,419,962
Shares Outstanding
49,820,000
Weighted SO
49,818,812
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
1.0650
Last Div
0.0000
Range
2.42-17.825
Chg
-0.0600
Avg Vol
1384811
Mkt Cap
136419962
Exch
NASDAQ
Country
US
Phone
650 466 7125
DCF Diff
2.4788
DCF
0.1212
Div Yield
0.0000
P/S
55.0080
EV Multiple
-0.7689
P/FV
0.8426
Div Yield %
0.0000
P/E
-0.7830
PEG
0.0334
Payout
0.0000
Current Ratio
4.3879
Quick Ratio
4.3879
Cash Ratio
0.4040
DSO
918.3871
DIO
0.0000
Op Cycle
918.3871
DPO
3497.9882
CCC
-2579.6011
Gross Margin
0.6573
Op Margin
-72.8165
Pretax Margin
-69.1298
Net Margin
-69.1298
Eff Tax Rate
-0.0065
ROA
-0.7988
ROE
-9.4688
ROCE
-1.0251
NI/EBT
1.0000
EBT/EBIT
0.9494
EBIT/Rev
-72.8165
Debt Ratio
0.0536
D/E
0.0723
LT Debt/Cap
0.0578
Total Debt/Cap
0.0674
Int Coverage
-205.2102
CF/Debt
-11.7553
Equity Multi
1.3471
Rec Turnover
0.3974
Pay Turnover
0.1043
Inv Turnover
0.0000
FA Turnover
0.2317
Asset Turnover
0.0116
OCF/Share
-2.6109
FCF/Share
-2.5932
Cash/Share
3.0237
OCF/Sales
-54.5673
FCF/OCF
0.9932
CF Coverage
-11.7553
ST Coverage
-77.6403
CapEx Coverage
-147.5758
Div&CapEx Cov
-147.5758
P/BV
0.8426
P/B
0.8426
P/S
55.0080
P/E
-0.7830
P/FCF
-1.0150
P/OCF
-0.9920
P/CF
-0.9920
PEG
0.0334
P/S
55.0080
EV Multiple
-0.7689
P/FV
0.8426
DPS
0.0000